Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
about
Pathogenesis of neonatal necrotizing enterocolitis.Alterations in the gut barrier and involvement of Toll-like receptor 4 in murine postoperative ileus.Intra-abdominal infection combined with intra-abdominal hypertension aggravates the intestinal mucosal barrier dysfunction.Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats.
P2860
Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
@en
Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
@nl
type
label
Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
@en
Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
@nl
prefLabel
Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
@en
Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
@nl
P2093
P2860
P1476
Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis
@en
P2093
Anatoly V Grishin
Elizabeth M Pontarelli
Henri R Ford
Nancy Smiley
Scott S Short
Shannon L Castle
Stephanie C Papillon
P2860
P2888
P304
P356
10.1038/LABINVEST.2013.119
P577
2013-10-14T00:00:00Z